Although serum AFP is primarily used as a marker for hepatocellular carcinoma, it can be also regularly elevated in a range of nonneoplastic liver diseases such as acute liver injury with extensive necrosis [25]. The gene discussed is AFP; the disease is hepatocellular carcinoma.